Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Bio-X Center Establish Translational Medicine Lab in Shanghai

NEW YORK (GenomeWeb News) – Qiagen today announced it and the Bio-X Center of Shanghai Jiao Tong University will jointly create a translational medicine laboratory in Shanghai.

The lab, which is the first of its kind between Qiagen and a major research institution in China, will be outfitted with Qiagen's Pyromark Q24MDx pyrosequencing instrument and QIAcube instruments, as well as related products. Bio-X Center will use the products in various research projects including biomarker validation and analysis.

"Through this agreement with the Bio-X Center we can leverage our leading positions as a solutions provider in biological research, drug discovery, and personalized healthcare to help develop better diagnostics and therapies for the Chinese people," Victor Shi, Asia Pacific president of Qiagen, said in a statement.

Though the deal is Qiagen's first in China creating a translational medicine lab, the company has forged other deals in Asia. In 2007, it opened a subsidiary in Hong Kong to be a hub for further expansion in the region. The same year, Qiagen formed a joint venture with Bio*One Capital in Singapore focused on developing molecular diagnostic assays.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.